SubHero Banner
Text

1st Quarter 2016

Key topics in this quarter’s edition include:

  • Sofosbuvir/velpatasvir for the treatment of Hepatitis C
  • Venetoclax for the treatment of chronic lymphocytic leukemia
  • Lixisenatide/insulin glargine for the treatment of type 2 diabetes mellitus

Download PDF

Text